New Form 8-K - Lifeward Ltd. Filed: 2025-08-05 AccNo: 0001178913-25-002629 Size: 207 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits
Assertio Holdings, Inc. - Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025
Veru to Report Fiscal 2025 Third Quarter Financial Results on August 12th
Conduit to Change Name to CDT Equity Inc.
Align Technology Announces $200 Million Open Market Repurchase
Spok-Powered Hospitals Achieve Recognition on U.S. News & World Report’s Best Hospitals Honor Roll
DarioHealth to Report Second Quarter 2025 Results on Tuesday, August 12, 2025
Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025
Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities
NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025
Senti Bio Determines Recommended Phase 2 Dose (RP2D) in Phase 1 Study of SENTI-202 for the Treatment of Relapsed/Refractory Hematologic Malignancies, Including Acute Myeloid Leukemia
Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025
Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space
Amwell set to continue to enable U.S. Defense Health Agency healthcare teams to deliver connected and seamless in-person and virtual care for the Military Health System (“MHS”)